BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 60 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $505,000 | +1288.0% | 100,000 | +394.8% | 0.02% | +2300.0% |
| Q4 2022 | $36,382 | -57.2% | 20,212 | -59.9% | 0.00% | -66.7% |
| Q3 2022 | $85,000 | -68.6% | 50,347 | -54.2% | 0.00% | -62.5% |
| Q2 2022 | $271,000 | +42.6% | 110,000 | +390.4% | 0.01% | +14.3% |
| Q3 2021 | $190,000 | – | 22,432 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $5,581,000 | 0.29% |
| NEA Management Company, LLC | 3,449,845 | $9,556,000 | 0.28% |
| Hawkeye Capital Management, LLC | 243,009 | $673,000 | 0.26% |
| DAFNA Capital Management LLC | 313,600 | $869,000 | 0.23% |
| Artal Group S.A. | 1,646,517 | $4,561,000 | 0.19% |
| MPM BioImpact LLC | 239,888 | $664,000 | 0.18% |
| RA Capital Management | 2,589,904 | $7,174,000 | 0.16% |
| Bellevue Group AG | 3,293,000 | $9,122,000 | 0.11% |
| Ikarian Capital, LLC | 159,390 | $441,000 | 0.06% |
| PDT Partners, LLC | 66,168 | $183,000 | 0.02% |